Motivation, acceptability and attitudes toward lung cancer screening among persons who attend a tobacco cessation program: A multicenter survey in Italy.
Decision aid
Low-dose computed tomography
Lung cancer screening
Smoking cessation
Survey
Journal
Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
05
12
2022
revised:
29
05
2023
accepted:
31
05
2023
medline:
29
6
2023
pubmed:
29
6
2023
entrez:
29
6
2023
Statut:
epublish
Résumé
This study aimed to evaluate smoking cessation (SC) motivation and the acceptability of a lung cancer screening (LCS) program with low-dose computed tomography (LDCT) among people who attend SC programs. A multicenter survey was conducted in the period January-December 2021 involving 197 people who attended group or individual SC courses in Reggio Emilia and Tuscany. Questionnaires, information sheets, and decision aids about the potential benefits and harms of LCS with LDCT were distributed at different time points during the course. The wish to protect own health (66%) was the most frequent reason given for quitting smoking, followed by cigarette dependence (40.6%) and current health problems (30.5%). Half of the participants (56%) considered periodic health checks including LDCT, as an advantageous activity. The great majority of participants were in favor of LCS (92%), with only 8% being indifferent, and no one was against these programs. Interestingly, those with sufficiently high smoking-related LC risk to be eligible for LCS and those attending the individual course were less in favor of LCS but also less concerned about the possible harms associated with LCS. The type of counseling was a significant predictor for both LCS acceptability and perceived harm of LCS. The favorable perception of LCS in people attending SC courses, despite the considerable preoccupation with potential harms, is an important finding of this study. Introducing a discussion on the benefits and harms of LCS in SC programs may prepare persons who smoke to make informed decisions on utilizing LCS.
Identifiants
pubmed: 37384117
doi: 10.1016/j.pmedr.2023.102272
pii: S2211-3355(23)00163-8
pmc: PMC10293766
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102272Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Chest. 2020 Dec;158(6):2646-2657
pubmed: 32629037
Singapore Med J. 2019 Nov;60(11):583-589
pubmed: 31781780
Addict Behav. 1997 Nov-Dec;22(6):727-39
pubmed: 9426790
Glob Public Health. 2020 Oct;15(10):1537-1550
pubmed: 32406331
BMC Cancer. 2018 May 2;18(1):497
pubmed: 29716550
Lancet Reg Health Eur. 2021 Sep 11;10:100179
pubmed: 34806061
Cancer Med. 2016 Apr;5(4):753-9
pubmed: 26822940
BMJ Open. 2016 Feb 29;6(2):e010227
pubmed: 26928026
Thorax. 2017 Sep;72(9):825-831
pubmed: 28377492
Health Expect. 2018 Aug;21(4):796-804
pubmed: 29473696
Ann Oncol. 2019 Jul 1;30(7):1162-1169
pubmed: 30937431
Cancer Res Treat. 2018 Oct;50(4):1096-1105
pubmed: 29141395
Eur Respir J. 2015 Jul;46(1):28-39
pubmed: 25929956
Transl Lung Cancer Res. 2021 Feb;10(2):1099-1109
pubmed: 33718048
JAMA. 2021 Jan 19;325(3):280-298
pubmed: 33464342
Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):400-5
pubmed: 25634890
Public Health. 2010 Apr;124(4):225-31
pubmed: 20371089
Eur J Cancer Prev. 2013 Jan;22(1):96-101
pubmed: 22644233
Nicotine Tob Res. 2020 Aug 24;22(9):1484-1491
pubmed: 31504798
Ann Am Thorac Soc. 2020 Sep;17(9):1126-1132
pubmed: 32603182
PLoS One. 2017 Dec 13;12(12):e0189148
pubmed: 29236722
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
Clin Lung Cancer. 2019 Jan;20(1):e115-e122
pubmed: 30585165
Prev Med. 2014 May;62:60-3
pubmed: 24518006
Thorax. 2017 Oct;72(10):870-871
pubmed: 28747323
Eur J Cancer Prev. 2021 Nov 1;30(6):457-461
pubmed: 33369949
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
J Thorac Oncol. 2020 Jul;15(7):1160-1169
pubmed: 32160967
JAMA Netw Open. 2020 Jan 3;3(1):e1920362
pubmed: 32003822
BMC Public Health. 2021 Jul 18;21(1):1419
pubmed: 34275456
Tob Induc Dis. 2011 Jan 24;9(1):2
pubmed: 21255463
Chest. 2020 Jul;158(1):386-392
pubmed: 32035910
J Thorac Oncol. 2022 Jan;17(1):160-166
pubmed: 34648947
JAMA. 2019 Aug 20;322(7):642-650
pubmed: 31429895
Tob Prev Cessat. 2020 Feb 12;6:12
pubmed: 32548349
J Natl Compr Canc Netw. 2018 Apr;16(4):412-441
pubmed: 29632061
Br J Cancer. 2016 Jun 14;114(12):e14
pubmed: 27228290
Eur Respir J. 2009 Sep;34(3):711-20
pubmed: 19282345
Br J Cancer. 2020 Sep;123(5):714-721
pubmed: 32546834